Observed EGFR-low expressing cells showed more invasive properties and modified the tumor microenvironment to potentiate cancer cell reoccurrence, indicating that protein expression heterogeneity can play an essential role in the development of drug resistance. This evidence concerns the gene EGFR and cancer.